Skip to main content
OpenTrials

Clinical trial condition

BRAF-Mutated Melanoma

Explore clinical trials studying BRAF-Mutated Melanoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

BRAF-Mutated Melanoma trial results

Completed

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

NCT02729298

Conditions
Adnexal Diseases, Advanced Solid Tumors, BRAF-Mutated Melanoma, +26 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of Colorado Denver Denver, Colorado, United States
  • US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) Denver, Colorado, United States
View all 16 locations
View Trial Details

Related conditions